Maravai Lifesciences Holdings (MRVI) Current Leases (2023 - 2025)
Maravai Lifesciences Holdings' (MRVI) quarterly Current Leases came in at $876000.0 in Q2 2025, up 23.38% year-on-year from $710000.0 in Q2 2024, and up 5.04% quarter-over-quarter from $834000.0 in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Current Leases (2023 - 2025) Analysis & Trends
Maravai Lifesciences Holdings' Current Leases history runs 3 years deep, the most recent figure standing at $876000.0 for Q2 2025.
- On a quarterly basis, Current Leases rose 23.38% year-over-year to $876000.0 in Q2 2025; TTM through Jun 2025 was $876000.0, a 23.38% increase from a year earlier, with the FY2024 full-year figure at $792000.0, up 25.12% from the prior year.
- Current Leases grew to $876000.0 in Q2 2025 per MRVI's latest filing, from $834000.0 in the prior quarter.
- Across five years, Current Leases topped out at $876000.0 in Q2 2025 and bottomed at $300000.0 in Q1 2023.
- The 3-year median for Current Leases is $691000.0 (2024), against an average of $672300.0.
- Across the five-year window, Current Leases jumped 124.0% in 2024 and advanced 23.38% in 2025, its largest moves.
- Year by year, Current Leases stood at $633000.0 in 2023, then grew by 25.12% to $792000.0 in 2024, then climbed by 10.61% to $876000.0 in 2025.
- Per Business Quant, the three latest MRVI Current Leases figures stand at $876000.0 (Q2 2025), $834000.0 (Q1 2025), and $792000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 876,000.00 |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 792,000.00 |
| Sep 30, 2024 | 750,000.00 |
| Jun 30, 2024 | 710,000.00 |
| Mar 31, 2024 | 672,000.00 |
| Dec 31, 2023 | 633,000.00 |
| Sep 30, 2023 | 596,000.00 |
| Jun 30, 2023 | 560,000.00 |
| Mar 31, 2023 | 300,000.00 |